MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX)
source: myfinsight.com
Download
Download image
Net loss
-$42,673K
Product
$48,923K
Collaboration Revenue
$15,941K
Loss from operations
-$34,202K
Total other (expense)
income, net
-$8,471K
Total revenues
$64,864K
Interest income
$3,561K
Total operating
expenses
$99,066K
Royalty interest
expense
$11,846K
Other expense
-$186K
Research and development
$58,845K
Selling, general and
administrative
$37,588K
Cost of product sales
$2,633K
Back